首页 > 市场调查报告书 > 医疗设备

体外诊断泌尿科

市场调查报告书

商品编码

1496875

全球尿液分析市场 - 2024-2031

Global Urinalysis Market - 2024-2031

出版日期: 2024年06月18日 | 出版商:

DataM Intelligence | 英文 182 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场动态

司机

尿路感染和泌尿系统疾病的盛行率上升

全球尿液分析市场的需求是由多种因素所驱动的。关键因素之一是泌尿道感染和泌尿系统疾病的盛行率上升。泌尿道感染（UTI）是全世界最常见的感染之一。

根据 2023 年 10 月的 BMC 传染病出版物，泌尿道感染 (UTI) 是第二常见传染病，每年影响全球超过 1.5 亿人。泌尿道致病性大肠桿菌 (UPEC) 是泌尿道感染的主要原因，可能以与抗菌素抗药性 (AMR) 相关的生物膜形式出现。

尿液颗粒分析和尿液沉渣测试是用于诊断肾臟和泌尿道疾病的重要测试。此测试透过对尿液中形成的颗粒（例如红血球、白血球和细菌）进行分类和测量来进行。

此外，该行业的主要参与者技术创新（例如尿路感染治疗中的人工智慧）有助于推动该市场的成长。例如，2024 年 1 月，硕腾公司 (Zoetis Inc.) 宣布扩展其多应用诊断平台 Vetscan Imagyst，将人工智慧尿液沉渣分析纳入其中。新的应用程式将能够对新鲜尿液进行准确的临床沉积物分析，使临床医生能够快速做出治疗决策。

此外，2023 年 1 月，Starling Medical 的新型尿液检测设备可将您的马桶变成健康追踪器。使用一些人工智慧和光谱感测器，导管将追踪患者膀胱中的尿液，以检测泌尿道感染，这可能导致住院和败血症。

限制

尿液分析测试和设备的高成本、严格的监管审批流程、尿液分析测试和解释的复杂性、医疗保健专业人员的意识有限和缺乏教育以及有限的报销政策等因素预计将阻碍市场。

有关此报告的更多详细资讯 - 索取样品

A urinalysis involves checking the appearance, concentration, and content of urine. For example, a urinary tract infection can make urine look cloudy instead of clear. Increased levels of protein in urine can be a sign of kidney disease. It plays a crucial role in the early detection and management of diseases, making it an essential diagnostic tool for healthcare professionals worldwide.

The major key factors driving the market are the rising prevalence of urinary tract infections & urological disorders, the growing geriatric population & the burden of chronic kidney diseases, the rising preference for point-of-care testing, and technological advancements in the healthcare industry.

Market Dynamics

Drivers

Rising Prevalence of Urinary Tract Infections & Urological Disorders

The demand for the global urinalysis market is driven by multiple factors. One of the key factors is the rising prevalence of UTI & urological disorders. Urinary tract infections (UTIs) are one of the most common infections worldwide.

As per BMC Infectious Disease publication in October 2023, urinary tract infection (UTI) is the second most common infectious disease affecting more than 150 million people globally annually. Uropathogenic E. coli (UPEC), the predominant cause of UTI, can occur as a biofilm-associated with antimicrobial resistance (AMR).

Urine particle analysis & urine sediment testing is an important test used to diagnose renal and urinary tract disorders. This test is conducted by classifying and measuring particles formed in urine, such as red blood cells, white blood cells, and bacteria.

Moreover, key players in the industry technological innovations such as AI in UTI treatment help to drive this market growth. For instance, in January 2024, Zoetis Inc., announced the expansion of its multi-application diagnostics platform, Vetscan Imagyst, to include AI Urine Sediment analysis. The new application will enable accurate, in-clinic sediment analysis of fresh urine, allowing clinicians to make treatment decisions quickly.

Also, in January 2023, Starling Medical's new urine-testing device turns your toilet into a health tracker. Using some AI and spectroscopy sensors, the catheter would track the urine still in a patient's bladder to detect urinary tract infections, which can lead to hospitalizations and sepsis.

Restraints

Factors such as the high cost of urinalysis tests & equipment, stringent regulatory approval process, complexity of urinalysis testing & interpretation, limited awareness & lack of education among healthcare professionals, and limited reimbursement policies are expected to hamper the market.

For more details on this report - Request for Sample

Segment Analysis

The global urinalysis market is segmented based on product, test type, application, end-user, and region.

The instruments segment accounted for approximately 43.3% of the global urinalysis market share

The instruments segment is expected to hold the largest market share over the forecast period. A urine analyzer is a device used in the clinical setting to perform automatic urine testing. The units can detect and quantify several analytes including bilirubin, protein, glucose, and red blood cells. Many models contain urine strip readers, a type of reflectance photometer that can process several hundred strips per hour.

In addition, major players in the industry launching new analyzers for UTI infections would propel this segment's growth. For instance, in December 2023, Siemens Healthineers now offer high-resolution, digital urine microscopy with its compact Atellica UAS 60 analyzer.

This is a compact solution for urine sediment analysis, that can automate a lab's urinalysis workflow with full field-of-view digital imaging that closely replicates manual microscopy. Laboratory professionals can more rapidly and accurately review and report urine sediment results by replacing routine manual microscopy with an automated, digital alternative.

Similarly, in April 2023, Sysmex Europe launched the UF-1500 Fully Automated Urine Particle Analyser (UF-1500), a new product for use in particle analysis. The UF-1500 inherits the high levels of functionality and usability of the UF-5000 Fully Automated Urine Particle Analyser (UF-5000), our flagship model in urine particle analysis while achieving a downsizing of the former model.

Geographical Analysis

North America accounted for approximately 45.6% of the global urinalysis market share

North America region is expected to hold the largest market share over the forecast period owing to the rising prevalence of UTI cases helping to drive this market growth. As per Medscape U.S. statistics in February 2024, UTIs in women are very common in the U.S., approximately 25-40% of women in the United States aged 20-40 years have had a UTI.

Furthermore, in this region, a major key player's presence, well-developed healthcare infrastructure, and innovative developments, urine test approvals would propel this market growth. For instance, in January 2023, Withings announced U-Scan, the world's first hands-free connected home urine lab.

Sophisticated urine analysis allows users to monitor metabolic insights and empowers women to manage monthly cycles ability of U-Scan to perform daily urine analysis from the home will allow Withings to take its mission to help consumers fully utilize urine data to an entirely new level.

Similarly, in October 2023, the Food and Drug Administration cleared for marketing the first over-the-counter test to detect fentanyl in urine.

Market Segmentation

By Product

Instruments
- Semi-Automated Urine Analyzers
- Automated Urine Analyzers
Consumables
- Disposables
- Dipsticks
- Reagents & Kits
- Others

By Test Type

Pregnancy & Fertility Tests
Sediment Urinalysis
Biochemical Urinalysis
- Point-Of-Care Tests
- Laboratory Tests

By Application

Urinary Tract Infections
Diabetes
Kidney Diseases
Liver Diseases
Others

By End-User

Hospitals
Home Care Settings
Diagnostic Laboratories
Research Laboratories & Academic Institutes
Others

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- U.K.
- France
- Spain
- Italy
- Rest of Europe
South America
- Brazil
- Argentina
- Rest of South America
Asia-Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Middle East and Africa

Competitive Landscape

The major global players in the urinalysis market include Abbott, Siemens Healthcare Private Limited, BD, Thermo Fisher Scientific, 77 Elektronika Kft, F. Hoffmann-La Roche Ltd, Beckman Coulter Inc, Sysmex, ACON Laboratories Inc, and Analyticon Biotechnologies GmbH among others.

Key Developments

In January 2024, Una Health Ltd was delighted to unveil the new, enhanced model of the Urisys 1100 Urine Analyser from Roche Diagnostics. Boasting a sleek and compact design, the Urisys 1100 stands out as one of the smallest and lightest devices in its class, designed for fast, safe, and accurate urinalysis.
In August 2023, Signify Health launches in-home testing for chronic kidney disease. It is expanding its services with the addition of a new in-home testing option for chronic kidney disease.
In February 2023, Sysmex introduced automated urinalysis testing solutions that revolutionized workflow at Medlab Middle East 2023. It presents its broad range of medical diagnostics products and solutions in the fields of hematology, urinalysis, hemostasis, and flow cytometry.
In January 2023, Vivoo announced the launch of the world's first smart toilet clip-on device that will help in the early detection of health conditions. The toilet is a game-changer for healthcare and caring professionals, enabling users to perform urine testing and receive personalized wellness, health, and nutritional recommendations without the mess.

Why Purchase the Report?

To visualize the global urinalysis market segmentation based on product, test type, application, end-user, and region, as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development
Excel data sheet with numerous data points of global urinalysis market level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping is available in excel consisting of key products of all the major players.

The global urinalysis market report would provide approximately 70 tables, 72 figures, and 182 Pages.

Target Audience 2024

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product
3.2. Snippet by Test Type
3.3. Snippet by Application
3.4. Snippet by End-User
3.5. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Rising Prevalence of Urinary Tract Infections & Urological Disorders
  - 4.1.1.2. Growing Geriatric Population & Burden of Chronic Kidney Disease
  - 4.1.1.3. Rising Preference for Point of Care Testing
  - 4.1.1.4. Technological Advancements in the Healthcare Industry
- 4.1.2. Restraints
  - 4.1.2.1. The High Cost of Urinalysis Tests & Equipment
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Unmet Needs
5.6. PESTEL Analysis
5.7. Patent Analysis
5.8. SWOT Analysis

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID
- 6.1.2. Scenario During COVID
- 6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers' Strategic Initiatives
6.6. Conclusion

7. By Product

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 7.1.2. Market Attractiveness Index, By Product
7.2. Instruments*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Semi-Automated Urine Analyzers
7.4. Automated Urine Analyzers
7.5. Consumables
7.6. Disposables
7.7. Dipsticks
7.8. Reagents & Kits
7.9. Others

8. By Test Type

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
- 8.1.2. Market Attractiveness Index, By Test Type
8.2. Pregnancy & Fertility Tests*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Sediment Urinalysis
8.4. Biochemical Urinalysis
8.5. Point-Of-Care Tests
8.6. Laboratory Tests

9. By Application

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.1.2. Market Attractiveness Index, By Application
9.2. Urinary Tract Infections *
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Diabetes
9.4. Kidney Diseases
9.5. Liver Diseases
9.6. Others

10. By End-User

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.1.2. Market Attractiveness Index, By End-User
10.2. Hospitals *
- 10.2.1. Introduction
- 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Home Care Settings
10.4. Diagnostic Laboratories
10.5. Research Laboratories & Academic Institutes
10.6. Others

11. By Region

11.1. Introduction
- 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 11.1.2. Market Attractiveness Index, By Region
11.2. North America
- 11.2.1. Introduction
- 11.2.2. Key Region-Specific Dynamics
- 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
- 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.2.7.1. U.S.
  - 11.2.7.2. Canada
  - 11.2.7.3. Mexico
11.3. Europe
- 11.3.1. Introduction
- 11.3.2. Key Region-Specific Dynamics
- 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
- 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.3.7.1. Germany
  - 11.3.7.2. UK
  - 11.3.7.3. France
  - 11.3.7.4. Italy
  - 11.3.7.5. Spain
  - 11.3.7.6. Rest of Europe
11.4. South America
- 11.4.1. Introduction
- 11.4.2. Key Region-Specific Dynamics
- 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
- 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.4.7.1. Brazil
  - 11.4.7.2. Argentina
  - 11.4.7.3. Rest of South America
11.5. Asia-Pacific
- 11.5.1. Introduction
- 11.5.2. Key Region-Specific Dynamics
- 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
- 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.5.7.1. China
  - 11.5.7.2. India
  - 11.5.7.3. Japan
  - 11.5.7.4. South Korea
  - 11.5.7.5. Rest of Asia-Pacific
11.6. Middle East and Africa
- 11.6.1. Introduction
- 11.6.2. Key Region-Specific Dynamics
- 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
- 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

12. Competitive Landscape

12.1. Competitive Scenario
12.2. Market Positioning/Share Analysis
12.3. Mergers and Acquisitions Analysis

13. Company Profiles

13.1. Abbott *
- 13.1.1. Company Overview
- 13.1.2. Product Portfolio & Description
- 13.1.3. Financial Overview
- 13.1.4. Key Developments
13.2. Siemens Healthcare Private Limited
13.3. BD
13.4. Thermo Fisher Scientific
13.5. 77 Elektronika Kft
13.6. F. Hoffmann-La Roche Ltd
13.7. Beckman Coulter Inc
13.8. Sysmex
13.9. ACON Laboratories Inc
13.10. Analyticon Biotechnologies GmbH

LIST NOT EXHAUSTIVE